News
Feb 2016
Scientists at Western University in London, Ontario have been using Apogee flow cytometers to rapidly and effectively test for prostate cancer.
Read more here.
Feb 2016
Apogee will be giving a presentation at the winter meeting of the NIH Flow Cytometry Interest Group. The theme of this meeting is New Instrument Technology and we will be presenting on current uses of Apogee technology as well as the latest developments by our R&team.
NIH Flow Cytometry Interest Group (FCIG)
Winter Meeting
Thursday, February 4, 2016
National Institutes of Health
Building 45 Natcher Center Balcony B
Sep 2015
The EURAMET (European Association of National Metrology Institutes) conclusions from the 3 year project "Metrological characterisation of microvesicles from body fluids as non-invasive diagnostic biomarkers" (METVES) validate Apogee's A50-Micro flow cytometer:
"To be noted, Apogee A50-Micro was developed for small (<1um) particle detection. Thus far, this flow cytometer is more sensitive in MV detection in comparison to other commercially available flow cytometers."...
Jun 2015
With no compromises, it is designed for small particle performance. By light scatter alone it resolves 80nm latex beads from noise and particle size differences as small as 10nm. Multiple high sensitivity light scatter and fluorescence detectors allow the study of particles far below the sensitivity limits of conventional flow cytometers. The Micro+ model is for research into extracellular vesicles (microparticles), virus and other nanoparticles.
May 2015
New "A50-Micro +" dedicated to analysis of microvesicles and large virus.
Apogee announces the launch date for this new version of the A50-Micro with uncompromised performance for the smallest particles measurable.
Available with higher power lasers, higher sensitivity photomultiplier detectors and more aggressively tuned optics, the A50-Micro + will secure Apogee's lead in small particle flow cytometry.